Trading floor, Nigerian Stock Exchange
The suspension of the chairman, managing
director and two other directors of Stanbic IBTC Holdings Plc by the
Financial Reporting Council of Nigeria for filing misleading financial
statements has taken a toll on the group’s shares and market
capitalisation.
A review of market statistics made
available by the Nigerian Stock Exchange showed that between Monday when
the FRC made its decision public and the close of trading on Tuesday,
Stanbic IBTC’s market capitalisation had fallen from N230bn to N207.6bn.
On Monday, the group’s share price fell
by five per cent or N1.15 from N23 to N21.85 before shedding an
additional 4.99 per cent or N1.09 to close at N20.76 on Tuesday.
The FRC had on Monday directed Stanbic
IBTC Holdings to withdraw and restate what it described as “misleading
financial statements” for the years ended December 31, 2013 and 2014.
It also suspended the group’s Chairman,
Mr. Atedo Peterside; Chief Executive Officer, Mrs. Sola David-Borha; two
other directors, Mr. Arthur Oginga and Dr. Daru Owei; and Ayodele
Othihiwa of KPMG Professional Services, the group’s auditors.
All five persons were suspended for attesting to the “misleading” financial position of Stanbic IBTC Holdings for the two years.
The council had in August opened an
investigation into Stanbic IBTC in response to a petition written by
shareholders of the bank, drawing the attention of the regulatory
authorities to some unapproved transactions allegedly conducted by the
bank with its foreign technical partners.
In the course of its investigation, the
FRC said it found out that Stanbic IBTC had violated provisions of the
International Financial Reporting Standards in its financial statements.
It added that it found technical issues
in the financial reports of the group as well as problems with statutory
audit and auditor independence, ] presentation of information with
regards to current and deferred tax liabilities, and instances where
information was concealed.
punch.com.ng
No comments:
Post a Comment